# RCT on the Efficacy of Methotrexate for the Prevention of GTD

> **NCT01984099** · PHASE3 · COMPLETED · sponsor: **University of the Philippines** · enrollment: 99 (actual)

## Conditions studied

- Hydatidiform Mole

## Interventions

- **DRUG:** Methotrexate
- **DRUG:** Vitamin B Complex

## Key facts

- **NCT ID:** NCT01984099
- **Lead sponsor:** University of the Philippines
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 99 (ACTUAL)
- **Last updated:** 2020-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01984099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01984099, "RCT on the Efficacy of Methotrexate for the Prevention of GTD". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01984099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*